WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that University of Iowa researchers in the Molecular Otolaryngology and Renal Research Labs (MORL) are utilizing GenomeQuest’s clinical decision support system, GQ-DxSM, to develop a first-of-its-kind molecular diagnostic test for individuals with hearing loss. The new diagnostic test screens in parallel all known genes associated with inherited deafness and will offer a significant improvement in time and cost over the current method of screening patients.
